Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
QJM ; 115(6): 351-358, 2022 Jun 07.
Article in English | MEDLINE | ID: mdl-33196834

ABSTRACT

Kyasanur forest disease (KFD) virus is a flavivirus that can be transmitted to humans from monkeys or other mammals through hard ticks (Haemaphysalis spinigera). The disease is endemic to 16 districts in 5 states of Southern India and is reported in the dry season, most commonly in humans travelling to the forests in these areas. The aim of this systematic review is to raise awareness of the clinical and laboratory manifestation of KFD among physicians and travel medicine practitioners. A total of 153 articles were screened of which 16 articles that met the inclusion and exclusion criteria were included for qualitative analysis. KFD is an acute haemorrhagic fever with a biphasic component in some individuals. The second phase is usually marked by neurological symptoms. Leucopoenia, thrombocytopenia and elevated transaminases are the hallmarks of the first phase of KFD. The diagnostic modality of choice in the first few days of illness is polymerase chain reaction assay, whereas serology is used in the late phase. In the absence of a specific antiviral treatment, the clinical management of patients is limited to supportive care. Avoidance of exposure and vaccination is recommended to prevent this infection.


Subject(s)
Encephalitis Viruses, Tick-Borne , Ixodidae , Kyasanur Forest Disease , Leukopenia , Animals , Humans , India/epidemiology , Kyasanur Forest Disease/diagnosis , Kyasanur Forest Disease/epidemiology , Kyasanur Forest Disease/therapy , Mammals , Travel
2.
Infez Med ; 28(4): 597-602, 2020 Nov 01.
Article in English | MEDLINE | ID: mdl-33257636

ABSTRACT

Kyasanur forest disease (KFD) is a biphasic tick-borne disease which occurs during the post-monsoon season. The patient may visit the hospital in either of the phases, and it is essential to differentiate between the two phases as the management considerations in both phases are different. This is a retrospective review of patients diagnosed with KFD who were treated by the Infectious Disease Department between September 2019 and May 2020. A total of 14 cases (16 admissions) were diagnosed during the study period by reverse-transcriptase polymerase chain reaction assay. Of these, nine cases came to our hospital during the first phase and seven (including two-readmissions) came to our hospital during the second phase. The manifestations in the first phase included high-grade fever (100%), myalgia (67%), conjunctival suffusion (33%), palatal eruptions (78%), gastrointestinal manifestations (67%), leucopenia (100%), thrombocytopenia (89%), elevated transaminases (89%), elevated creatine phosphokinase (100%) and activated partial thromboplastin time (APTT) (100%). Manifestations in the second phase were fever (57%), headache (100%), blurring of vision (29%), neck signs (71%), leukocytosis (71%), thrombocytopenia (14%), elevated transaminases (40%) and APTT (20%). The clinical symptomatology and laboratory manifestations are different in each of the two phases and can be easily identified by primary care physicians.


Subject(s)
Hospitals, Teaching , Kyasanur Forest Disease , Humans , India , Kyasanur Forest Disease/complications , Kyasanur Forest Disease/diagnosis , Kyasanur Forest Disease/therapy , Retrospective Studies
3.
Indian J Med Res ; 148(2): 145-150, 2018 Aug.
Article in English | MEDLINE | ID: mdl-30381537

ABSTRACT

Kyasanur forest disease (KFD) is a known viral haemorrhagic fever in India, for the last 60 years. However, in recent years, the change in epidemiological profile of the disease has suggested that it is now time to consider KFD as an emerging tropical disease in India. The preference should be to educate not only the villagers where it is being reported or detected but also to public health experts, veterinarians, forest officials and medical professionals to pay attention while seeing a patient overlapping with endemic diseases such as Japanese encephalitis, West Nile, dengue, chikungunya, malaria and tuberculosis. Although the existence of KFD is known for a long time, updated understanding of its clinical profile in humans is still limited. This article describes in detail the clinical presentation of KFD reported till date. It also highlights geographical distribution of the disease, risk factors for virus transmission, biochemical/haematological findings and control measures. There is an urgent need for research on KFD, particularly for understanding biphasic nature of illness, development of cost-effective diagnostic tools, utility of non-invasive samples for diagnosis and development of new vaccines.


Subject(s)
Endemic Diseases , Kyasanur Forest Disease/epidemiology , Kyasanur Forest Disease/virology , Chikungunya Fever/epidemiology , Chikungunya Fever/virology , Dengue/epidemiology , Dengue/virology , Disease Outbreaks , Encephalitis Viruses, Tick-Borne/pathogenicity , Humans , India/epidemiology , Kyasanur Forest Disease/therapy , Malaria/epidemiology , Malaria/parasitology , Tuberculosis/epidemiology , Tuberculosis/microbiology
4.
J Nepal Health Res Counc ; 14(34): 214-218, 2016 Sep.
Article in English | MEDLINE | ID: mdl-28327690

ABSTRACT

Kyasanur forest disease (KFD) is a rare tick borne zoonotic disease that causes acute febrile hemorrhagic illness in humans and monkeys especially in southern part of India. The disease is caused by highly pathogenic KFD virus (KFDV) which belongs to member of the genus Flavivirus and family Flaviviridae. The disease is transmitted to monkeys and humans by infective tick Haemaphysalisspinigera. Seasonal outbreaks are expected to occur during the months of January to June. The aim of this paper is to briefly summarize the epidemiology, mode of transmission of KFD virus, clinical findings, diagnosis, treatment, control and prevention of the disease..


Subject(s)
Kyasanur Forest Disease/epidemiology , Kyasanur Forest Disease/physiopathology , Rare Diseases/epidemiology , Rare Diseases/physiopathology , Tick-Borne Diseases/epidemiology , Tick-Borne Diseases/physiopathology , Encephalitis Viruses, Tick-Borne , Humans , India/epidemiology , Kyasanur Forest Disease/therapy , Kyasanur Forest Disease/transmission , Nepal , Rare Diseases/therapy , Tick-Borne Diseases/therapy , Tick-Borne Diseases/transmission , Viral Vaccines
SELECTION OF CITATIONS
SEARCH DETAIL
...